Skip to main content

Table 5 Changes of PANSS, PSP and ROMI total and subscales score over the 1-year observational therapeutic study

From: Remission in schizophrenia: results of cross-sectional with 6-month follow-up period and 1-year observational therapeutic studies in an outpatient population

PANSS score Risperidone (long-acting, injectable) (RLAI) group, n = 42 Routine treatment group, n = 35 Mann-Whitney test (between groups)
PANSS total score (SD)  
1 day 66.1 (10.7) 68.7 (12.3) -
12 month 57.0 (13.8) *** 64.0 (13.4)* < 0.01
PANSS positive score (items 1 to 7) (SD)  
1 day 14.5 (4.5) 16.0 (5.1) -
12 month 13.0 (5.3)* 14.8 (5.5) < 0.01
PANSS negative score (items 8 to 14) (SD)  
1 day 18.8 (4.3) 19.1 (4.8) -
12 month 16.9 (4.8)** 18.7 (5.6) < 0.05
PANSS general score (items 15 to 30) (SD)  
1 day 33.1 (5.4) 35.3 (5.4) -
12 month 27.1 (7.0)*** 33.2 (6.8)* < 0.001
PSP score (SD)  
1 day 52.0 (12.3) 51,3 (13.1) -
12 month 60.1 (12.3)*** 53.6 (13.5)* < 0.0001
ROMI, compliance subscale score (SD)  
1 day 14.9 (2.3) 15.7 (3.0) -
12 month 15.2 (2.5) 15.5 (2.9) -
ROMI, non-compliance subscale score (SD)  
1 day 17.1 (3.3) 16.4 (4.1) -
12 month 15.3 (3.4)*** 16.0 (2.9) < 0.05
  1. Wilcoxon test (baseline vs end point): *P < 0.05; **P < 0.01; ***P < 0.001.
  2. PANSS = Positive and Negative Syndrome Scale; PSP = Personal and Social Performance; ROMI = Rating of Medication Influences.